Article
Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
European journal of clinical nutrition - 1 Sept 2007
Ukkola O, Kesäniemi Y A
Abstract excerpt
OBJECTIVES: Neuropeptide Y (NPY) plays a central in energy homeostasis and potentially in the development of obesity-related comorbidities, like type II diabetes. As the PreproNPY Leu7Pro polymorphism probably changes the intracellular processing of the synthesized preproNPY peptide, we assessed the hypothesis that PreproNPY Leu7Pro polymorphism is a risk factor for type II diabetes, impaired glucose tolerance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
